CD8A and nasopharyngeal carcinoma: On the other hand, the frequency of TIM-3/2B4 double positive CD8+ T cells was 0.83% (IQR 0.5%–1.31%) in the NPC group and 0.365% (IQR 0.228%–0.635%) in healthy controls.